157 related articles for article (PubMed ID: 3104957)
1. Latent inhibition is not affected by acute or chronic administration of 6 mg/kg dl-amphetamine.
Weiner I; Izraeli-Telerant A; Feldon J
Psychopharmacology (Berl); 1987; 91(3):345-51. PubMed ID: 3104957
[TBL] [Abstract][Full Text] [Related]
2. Phencyclidine does not disrupt latent inhibition in rats: implications for animal models of schizophrenia.
Weiner I; Feldon J
Pharmacol Biochem Behav; 1992 Aug; 42(4):625-31. PubMed ID: 1513845
[TBL] [Abstract][Full Text] [Related]
3. Abolition of the expression but not the acquisition of latent inhibition by chronic amphetamine in rats.
Weiner I; Lubow RE; Feldon J
Psychopharmacology (Berl); 1984; 83(2):194-9. PubMed ID: 6431473
[TBL] [Abstract][Full Text] [Related]
4. Facilitation of latent inhibition by haloperidol in rats.
Weiner I; Feldon J
Psychopharmacology (Berl); 1987; 91(2):248-53. PubMed ID: 3107041
[TBL] [Abstract][Full Text] [Related]
5. Abolition of the acquisition but not the expression of latent inhibition by chlordiazepoxide in rats.
Feldon J; Weiner I
Pharmacol Biochem Behav; 1989 Jan; 32(1):123-7. PubMed ID: 2734324
[TBL] [Abstract][Full Text] [Related]
6. Disruption of latent inhibition by acute administration of low doses of amphetamine.
Weiner I; Lubow RE; Feldon J
Pharmacol Biochem Behav; 1988 Aug; 30(4):871-8. PubMed ID: 3227035
[TBL] [Abstract][Full Text] [Related]
7. Amphetamine-induced disruption and haloperidol-induced potentiation of latent inhibition depend on the nature of the stimulus.
Ruob C; Elsner J; Weiner I; Feldon J
Behav Brain Res; 1997 Oct; 88(1):35-41. PubMed ID: 9401706
[TBL] [Abstract][Full Text] [Related]
8. The sigma ligand BMY-14802 as a potential antipsychotic: evidence from the latent inhibition model in rats.
Weiner I; Traub A; Rawlins JN; Smith AD; Feldon J
Behav Pharmacol; 1995 Jan; 6(1):46-54. PubMed ID: 11224311
[TBL] [Abstract][Full Text] [Related]
9. A neuroleptic-like effect of ceronapril on latent inhibition.
Weiner I; Smith AD; Rawlins JN; Feldon J
Neuroscience; 1992 Jul; 49(2):307-15. PubMed ID: 1359453
[TBL] [Abstract][Full Text] [Related]
10. The effects of the new antipsychotic, sertindole, on latent inhibition in rats.
Weiner I; Kidron R; Tarrasch R; Arnt J; Feldon J
Behav Pharmacol; 1994 Apr; 5(2):119-124. PubMed ID: 11224259
[TBL] [Abstract][Full Text] [Related]
11. The latent inhibition model of schizophrenic attention disorder. Haloperidol and sulpiride enhance rats' ability to ignore irrelevant stimuli.
Feldon J; Weiner I
Biol Psychiatry; 1991 Apr; 29(7):635-46. PubMed ID: 2054435
[TBL] [Abstract][Full Text] [Related]
12. Basolateral amygdala lesions do not disrupt latent inhibition.
Weiner I; Tarrasch R; Feldon J
Behav Brain Res; 1995 Dec; 72(1-2):73-81. PubMed ID: 8788859
[TBL] [Abstract][Full Text] [Related]
13. Amphetamine-induced disruption of latent inhibition depends on the nature of the stimulus.
Weiner I; Bernasconi E; Broersen LM; Feldon J
Behav Pharmacol; 1997 Oct; 8(5):442-57. PubMed ID: 9832983
[TBL] [Abstract][Full Text] [Related]
14. Haloperidol- and clozapine-induced enhancement of latent inhibition with extended conditioning: implications for the mechanism of action of neuroleptic drugs.
Weiner I; Shadach E; Barkai R; Feldon J
Neuropsychopharmacology; 1997 Jan; 16(1):42-50. PubMed ID: 8981387
[TBL] [Abstract][Full Text] [Related]
15. Amphetamine-induced disruptions of latent inhibition are reinforcer mediated: implications for animal models of schizophrenic attentional dysfunction.
Killcross AS; Dickinson A; Robbins TW
Psychopharmacology (Berl); 1994 Jun; 115(1-2):185-95. PubMed ID: 7862894
[TBL] [Abstract][Full Text] [Related]
16. Antagonism of amphetamine-induced disruption of latent inhibition by the atypical antipsychotic olanzapine in rats.
Gosselin G; Oberling P; Di Scala G
Behav Pharmacol; 1996 Dec; 7(8):820-826. PubMed ID: 11224476
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of intra-accumbens and systemic amphetamine on latent inhibition using an on-baseline, within-subject conditioned suppression paradigm.
Killcross AS; Robbins TW
Psychopharmacology (Berl); 1993; 110(4):479-89. PubMed ID: 7870920
[TBL] [Abstract][Full Text] [Related]
18. Nicotine blocks latent inhibition in rats: evidence for a critical role of increased functional activity of dopamine in the mesolimbic system at conditioning rather than pre-exposure.
Joseph MH; Peters SL; Gray JA
Psychopharmacology (Berl); 1993; 110(1-2):187-92. PubMed ID: 7870882
[TBL] [Abstract][Full Text] [Related]
19. Differential involvement of the shell and core subterritories of the nucleus accumbens in latent inhibition and amphetamine-induced activity.
Weiner I; Gal G; Rawlins JN; Feldon J
Behav Brain Res; 1996 Nov; 81(1-2):123-33. PubMed ID: 8950008
[TBL] [Abstract][Full Text] [Related]
20. The latent inhibition model of schizophrenia: further validation using the atypical neuroleptic, clozapine.
Weiner I; Shadach E; Tarrasch R; Kidron R; Feldon J
Biol Psychiatry; 1996 Nov; 40(9):834-43. PubMed ID: 8896769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
